Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ascendis Pharma A/SASND · Entity 1628 | EVP & Chief Financial Officer | June 02, 2026 | June 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ascendis Pharma A/S
Report date June 02, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 4,367 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Purchase · Acquired 100 · Balance 4,367 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 2, 2026 20:25 UTC | Ascendis Pharma A/S ASND · Entity 1628 | PurchaseOrdinary Shares | 100 | $219.00 | $21,900.00 |
DisclosureSEC source: 0001610717-26-000179 · form4.xml · nonDerivative · entry 1 SMITH SCOTT THOMAS · CIK 0001965550 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,367 Read SEC document |
| May 29, 2026 Filed Jun 1, 2026 20:10 UTC | Ascendis Pharma A/S ASND · Entity 1628 | PurchaseOrdinary Shares | 250 | $223.32 | $55,830.00 |
DisclosureSEC source: 0001610717-26-000176 · form4.xml · nonDerivative · entry 1 SMITH SCOTT THOMAS · CIK 0001965550 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,267 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.